Drug liberalization ballot initiative
cost-effectiveness analysis

In a nutshell:

Q & A:

What intervention is being modeled, exactly?

Why model mental health impacts if the largest benefits would come from other impacts?

Is a drug liberalization ballot initiative cost-effective on the grounds of mental health benefits alone?

Why doesn't the model account for adverse effects of psychedelics, like bad trips?

One plausible strategy for increasing access to psychedelics is to decriminalize all drugs. Wouldn't all-drug decriminalization cause a major uptick in use of addictive drugs?

Release notes: